SUMMARY In a double-blind study the therapeutic efficacy of a single 500-mg clotrimazole pessary was compared with that of a 200-mg clotrimazole pessary inserted once daily for three days in 72 patients with vaginal candidosis confirmed by culture. On clinical assessment four weeks after completion of treatment with the single-dose pessary the cure rate was 86% compared with 92% after the three-day regimen. There was no significant difference in the eradication rate between the single-dose (94070) and three-day regimens (89%o). Four weeks after completion of treatment the recurrence rates by culture were 18% with the single-dose and 24% with the threeday regimen. The former treatment was well tolerated and as effective as the three-day clotrimazole regimen.
Introduction
Clotrimazole, one of the imidazole antimycotics, in a dosage of 100 mg given for six days was found to be effective in the treatment of vaginal candidosis.' Shorter periods of treatment of four2 or three3 4 days did not affect the efficacy of the treatment. Clotrimazole is fungicidal in vaginal secretions at a concentration of >10 jig/ml5 and remains at this concentration for 72 hours after insertion of one 500-mg clotrimazole pessary (Ritter et al, unpublished data). We evaluated, therefore, the therapeutic efficacy and local tolerance of a single 500-mg clotrimazole pessary for the treatment of vaginal candidosis.
Patients and methods
Women with all the following criteria for vaginal candidosis were included in the study: (a) symptoms of irritation, burning, and vaginal discharge; (b) signs of inflammation of the vaginal mucosa and microscopical identification of pseudohyphae; and (c) cultural isolation of Candida albicans.
The culture specimens were promptly inoculated on to standard media and growing yeasts were identified as C albicans by the formation of The results of the two treatment regimens were compared using the x2 test with Yates's correction (significance, P<0-05).
Results
As treatment was started before mycological confirmation it was necessary to exclude seven women with negative culture results for Candida and one with positive culture results for both C albicans and C trachomatis. None of the patients had gonorrhoea as judged by culture samples from the cervix, urethra, and rectum. Seventy-two patients, ranging in age from 16-56 years, satisfied the criteria for inclusion and subsequently completed the trial. The characteristics of the two groups were similar ( Four weeks after completing treatment five patients who had received a single 500-mg clotrimazole pessary and three the three-day regimen had signs and symptoms of vaginal candidosis (table III) . This gave a cure rate of 85-7% four weeks after completion of the single-dose regimen and 91 -9/o for the patients given the three-day regimen. The difference in cure rates was not statistically significant (XI =0-.21, PA0*05).
ERADICATION RATE
The eradication rate, based on a negative culture result for C albicans, seven days after treatment with a single clotrimazole pessary was 94' 3%To and that for the three-day regimen 89' 2% (table III) . The difference in eradication rates was not statistically significant (XI = 0-13, P>0-05).
RECURRENCE RATE
Four weeks after completion of treatment the recurrence rate, as judged by culture, was 18-207o with 
